Logo image of CRM

SALESFORCE INC (CRM) Stock Fundamental Analysis

NYSE:CRM - New York Stock Exchange, Inc. - US79466L3024 - Common Stock - Currency: USD

309.8  -8.63 (-2.71%)

After market: 309.82 +0.02 (+0.01%)

Fundamental Rating

7

CRM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. Both the health and profitability get an excellent rating, making CRM a very profitable company, without any liquidiy or solvency issues. CRM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make CRM suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CRM was profitable.
In the past year CRM had a positive cash flow from operations.
In the past 5 years CRM has always been profitable.
In the past 5 years CRM always reported a positive cash flow from operatings.
CRM Yearly Net Income VS EBIT VS OCF VS FCFCRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

CRM's Return On Assets of 6.49% is amongst the best of the industry. CRM outperforms 80.80% of its industry peers.
The Return On Equity of CRM (10.14%) is better than 78.99% of its industry peers.
CRM has a Return On Invested Capital of 8.05%. This is amongst the best in the industry. CRM outperforms 82.25% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRM is significantly below the industry average of 11.91%.
The 3 year average ROIC (3.04%) for CRM is below the current ROIC(8.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.49%
ROE 10.14%
ROIC 8.05%
ROA(3y)1.96%
ROA(5y)2.45%
ROE(3y)3.26%
ROE(5y)3.99%
ROIC(3y)3.04%
ROIC(5y)2.16%
CRM Yearly ROA, ROE, ROICCRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

CRM has a Profit Margin of 15.96%. This is amongst the best in the industry. CRM outperforms 81.88% of its industry peers.
CRM's Profit Margin has improved in the last couple of years.
CRM has a Operating Margin of 19.75%. This is amongst the best in the industry. CRM outperforms 86.96% of its industry peers.
CRM's Operating Margin has improved in the last couple of years.
CRM's Gross Margin of 76.94% is fine compared to the rest of the industry. CRM outperforms 71.74% of its industry peers.
CRM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.75%
PM (TTM) 15.96%
GM 76.94%
OM growth 3Y100.32%
OM growth 5Y32.39%
PM growth 3Y-14.76%
PM growth 5Y7.26%
GM growth 3Y0.48%
GM growth 5Y0.4%
CRM Yearly Profit, Operating, Gross MarginsCRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRM is destroying value.
CRM has less shares outstanding than it did 1 year ago.
CRM has more shares outstanding than it did 5 years ago.
CRM has a better debt/assets ratio than last year.
CRM Yearly Shares OutstandingCRM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CRM Yearly Total Debt VS Total AssetsCRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 6.49 indicates that CRM is not in any danger for bankruptcy at the moment.
The Altman-Z score of CRM (6.49) is better than 72.46% of its industry peers.
The Debt to FCF ratio of CRM is 0.71, which is an excellent value as it means it would take CRM, only 0.71 years of fcf income to pay off all of its debts.
CRM has a better Debt to FCF ratio (0.71) than 73.91% of its industry peers.
CRM has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
CRM has a Debt to Equity ratio (0.14) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.71
Altman-Z 6.49
ROIC/WACC0.58
WACC13.9%
CRM Yearly LT Debt VS Equity VS FCFCRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

CRM has a Current Ratio of 1.11. This is a normal value and indicates that CRM is financially healthy and should not expect problems in meeting its short term obligations.
CRM's Current ratio of 1.11 is on the low side compared to the rest of the industry. CRM is outperformed by 71.74% of its industry peers.
A Quick Ratio of 1.11 indicates that CRM should not have too much problems paying its short term obligations.
CRM has a worse Quick ratio (1.11) than 70.65% of its industry peers.
CRM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
CRM Yearly Current Assets VS Current LiabilitesCRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

8

3. Growth

3.1 Past

CRM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.63%, which is quite impressive.
The Earnings Per Share has been growing by 26.05% on average over the past years. This is a very strong growth
The Revenue has grown by 9.53% in the past year. This is quite good.
The Revenue has been growing by 21.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)27.63%
EPS 3Y18.61%
EPS 5Y26.05%
EPS Q2Q%14.22%
Revenue 1Y (TTM)9.53%
Revenue growth 3Y17.93%
Revenue growth 5Y21.28%
Sales Q2Q%8.3%

3.2 Future

The Earnings Per Share is expected to grow by 13.88% on average over the next years. This is quite good.
Based on estimates for the next years, CRM will show a quite strong growth in Revenue. The Revenue will grow by 9.33% on average per year.
EPS Next Y23.38%
EPS Next 2Y17.24%
EPS Next 3Y16%
EPS Next 5Y13.88%
Revenue Next Year9.04%
Revenue Next 2Y9.05%
Revenue Next 3Y9.21%
Revenue Next 5Y9.33%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRM Yearly Revenue VS EstimatesCRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
CRM Yearly EPS VS EstimatesCRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.94, which means the current valuation is very expensive for CRM.
Based on the Price/Earnings ratio, CRM is valued a bit cheaper than the industry average as 68.48% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 29.63. CRM is around the same levels.
With a Price/Forward Earnings ratio of 27.45, CRM can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, CRM is valued a bit cheaper than the industry average as 70.29% of the companies are valued more expensively.
CRM is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.94
Fwd PE 27.45
CRM Price Earnings VS Forward Price EarningsCRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRM is valued a bit cheaper than the industry average as 78.26% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CRM is valued a bit cheaper than 77.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.97
EV/EBITDA 27.13
CRM Per share dataCRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

CRM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CRM has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRM's earnings are expected to grow with 16.00% in the coming years.
PEG (NY)1.37
PEG (5Y)1.23
EPS Next 2Y17.24%
EPS Next 3Y16%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.49%, CRM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 12.71, CRM pays a better dividend. On top of this CRM pays more dividend than 89.86% of the companies listed in the same industry.
With a Dividend Yield of 0.49, CRM pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 0.49%

5.2 History

CRM does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRM Yearly Dividends per shareCRM Yearly Dividends per shareYearly Dividends per share 2024 0.5 1 1.5

5.3 Sustainability

DPN/A
EPS Next 2Y17.24%
EPS Next 3Y16%
CRM Yearly Income VS Free CF VS DividendCRM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

SALESFORCE INC

NYSE:CRM (2/21/2025, 8:10:55 PM)

After market: 309.82 +0.02 (+0.01%)

309.8

-8.63 (-2.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-03 2024-12-03/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners83.35%
Inst Owner Change1.61%
Ins Owners2.57%
Ins Owner Change-1.94%
Market Cap296.48B
Analysts78.93
Price Target406.8 (31.31%)
Short Float %1.05%
Short Ratio1.45
Dividend
Industry RankSector Rank
Dividend Yield 0.49%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.61%
Min EPS beat(2)-2.3%
Max EPS beat(2)7.51%
EPS beat(4)3
Avg EPS beat(4)1.77%
Min EPS beat(4)-2.3%
Max EPS beat(4)7.51%
EPS beat(8)7
Avg EPS beat(8)5.64%
EPS beat(12)11
Avg EPS beat(12)7.56%
EPS beat(16)15
Avg EPS beat(16)16.26%
Revenue beat(2)1
Avg Revenue beat(2)0%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.02%
Revenue beat(4)1
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-1.45%
Max Revenue beat(4)0.02%
Revenue beat(8)2
Avg Revenue beat(8)0.12%
Revenue beat(12)3
Avg Revenue beat(12)-0.07%
Revenue beat(16)6
Avg Revenue beat(16)0.1%
PT rev (1m)-0.59%
PT rev (3m)27.32%
EPS NQ rev (1m)-1.51%
EPS NQ rev (3m)-2.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.77%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 31.94
Fwd PE 27.45
P/S 7.97
P/FCF 24.97
P/OCF 23.67
P/B 5.07
P/tB 55.8
EV/EBITDA 27.13
EPS(TTM)9.7
EY3.13%
EPS(NY)11.28
Fwd EY3.64%
FCF(TTM)12.41
FCFY4.01%
OCF(TTM)13.09
OCFY4.22%
SpS38.86
BVpS61.15
TBVpS5.55
PEG (NY)1.37
PEG (5Y)1.23
Profitability
Industry RankSector Rank
ROA 6.49%
ROE 10.14%
ROCE 10.2%
ROIC 8.05%
ROICexc 9.79%
ROICexgc 95.87%
OM 19.75%
PM (TTM) 15.96%
GM 76.94%
FCFM 31.93%
ROA(3y)1.96%
ROA(5y)2.45%
ROE(3y)3.26%
ROE(5y)3.99%
ROIC(3y)3.04%
ROIC(5y)2.16%
ROICexc(3y)3.74%
ROICexc(5y)2.67%
ROICexgc(3y)43.92%
ROICexgc(5y)30.47%
ROCE(3y)3.85%
ROCE(5y)2.73%
ROICexcg growth 3Y151.79%
ROICexcg growth 5Y-14.84%
ROICexc growth 3Y101.5%
ROICexc growth 5Y22.33%
OM growth 3Y100.32%
OM growth 5Y32.39%
PM growth 3Y-14.76%
PM growth 5Y7.26%
GM growth 3Y0.48%
GM growth 5Y0.4%
F-Score9
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.71
Debt/EBITDA 0.77
Cap/Depr 18.32%
Cap/Sales 1.75%
Interest Coverage 31.11
Cash Conversion 114.95%
Profit Quality 200.07%
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 6.49
F-Score9
WACC13.9%
ROIC/WACC0.58
Cap/Depr(3y)20.47%
Cap/Depr(5y)23.29%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.89%
Profit Quality(3y)1210.2%
Profit Quality(5y)1331.61%
High Growth Momentum
Growth
EPS 1Y (TTM)27.63%
EPS 3Y18.61%
EPS 5Y26.05%
EPS Q2Q%14.22%
EPS Next Y23.38%
EPS Next 2Y17.24%
EPS Next 3Y16%
EPS Next 5Y13.88%
Revenue 1Y (TTM)9.53%
Revenue growth 3Y17.93%
Revenue growth 5Y21.28%
Sales Q2Q%8.3%
Revenue Next Year9.04%
Revenue Next 2Y9.05%
Revenue Next 3Y9.21%
Revenue Next 5Y9.33%
EBIT growth 1Y36.26%
EBIT growth 3Y136.24%
EBIT growth 5Y60.57%
EBIT Next Year50.08%
EBIT Next 3Y20.58%
EBIT Next 5Y12.47%
FCF growth 1Y113.64%
FCF growth 3Y32.41%
FCF growth 5Y27.64%
OCF growth 1Y98.65%
OCF growth 3Y28.7%
OCF growth 5Y24.67%